Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$4.34
$0.57515.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -90.99% | 57.76% | -86.30% | -17.34% | -5.52% |
| Total Depreciation and Amortization | -44.44% | 125.00% | -20.00% | -47.37% | -5.00% |
| Total Amortization of Deferred Charges | -- | -100.00% | -35.99% | -13.24% | -4.87% |
| Total Other Non-Cash Items | 488.40% | -128.22% | 167.47% | 50,700.00% | 100.61% |
| Change in Net Operating Assets | 91.78% | -194.61% | 2,311.89% | -6.79% | -74.52% |
| Cash from Operations | 6.07% | -34.60% | -42.83% | -12.93% | -16.65% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 43.05% | 1,043.14% | 16.44% |
| Cash from Investing | -- | -100.00% | 43.05% | 1,043.14% | 16.44% |
| Total Debt Issued | -- | 216.00% | -- | -- | -- |
| Total Debt Repaid | 63.22% | 51.55% | 31.21% | -- | -- |
| Issuance of Common Stock | 35.49% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -41.35% | -59.10% | -354.25% | 200.00% | -- |
| Cash from Financing | 14.95% | 2,363.06% | 57.37% | -1,054.25% | 88.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 47.01% | 427.24% | 23.34% | 40.31% | 10.06% |